These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17578031)

  • 1. [Transplant patient monitoring].
    Caillard S; Moulin B
    Rev Prat; 2007 Feb; 57(3):299-308. PubMed ID: 17578031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect effects of CMV in the solid organ transplant patient.
    Paya CV
    Transpl Infect Dis; 1999; 1 Suppl 1():8-12. PubMed ID: 11565588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing complications in heart transplant recipients. Improved techniques and medications increase survival rates.
    Kobashigawa JA; Stevenson LW
    J Crit Illn; 1993 Jun; 8(6):678-89. PubMed ID: 10148766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infectious complications due to immunosuppression in organ transplant patients].
    Morelon E; Touraine JL
    Rev Prat; 2007 Oct; 57(15):1677-86. PubMed ID: 18080426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the well renal transplant recipient: outpatient surveillance and treatment recommendations.
    Salifu MO; Tedla F; Markell MS
    Semin Dial; 2005; 18(6):520-8. PubMed ID: 16398716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients.
    Ho WL; Murphy GM
    Br J Dermatol; 2008 Feb; 158(2):217-24. PubMed ID: 18070205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New immunosuppressive strategies and the risk of infection.
    Mueller NJ
    Transpl Infect Dis; 2008 Dec; 10(6):379-84. PubMed ID: 18811628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The follow-up of the heart transplant patient].
    Perini G; Bonadiman C
    G Ital Cardiol; 1998 Dec; 28(12):1378-84. PubMed ID: 9887391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the kidney transplant recipient.
    Padiyar A; Akoum FH; Hricik DE
    Prim Care; 2008 Sep; 35(3):433-50, v. PubMed ID: 18710663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infections in solid organ transplant recipients].
    Cuellar-Rodríguez J; Sierra-Madero JG
    Rev Invest Clin; 2005; 57(2):368-80. PubMed ID: 16524080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune monitoring of kidney transplant recipients: can markers predictive of over-immunosuppression be identified?].
    Saas P; Courivaud C; Bamoulid J; Garnache-Ottou F; Seilles E; Ducloux D
    Ann Pharm Fr; 2008 Mar; 66(2):115-21. PubMed ID: 18570910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the liver transplant patient.
    Gelb B; Feng S
    Expert Rev Gastroenterol Hepatol; 2009 Dec; 3(6):631-47. PubMed ID: 19929584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of immune monitoring in solid organ transplantation.
    Daniel V; Opelz G
    Int Rev Immunol; 2009; 28(3-4):155-84. PubMed ID: 19811320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
    Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.